Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Abivax, absent, Alameda, alongside, Alta, Amsterdam, andr, antioxidant, arena, areoverweight, Arko, ATMP, Azerbaijan, Bay, belong, Berkeley, biopharma, bladder, Boxenbaum, broadly, Brosgart, Carol, CC, Cede, Cellixir, channel, CMV, concealing, confounding, conspiring, ContraVir, council, County, cybersecurity, database, DCP, defense, defraud, delayAramchol, Depository, devision, Dir, distant, downregulated, drawn, editorial, EITF, electrical, element, enjoy, erode, error, expectedly, explicit, factorial, falsifying, FCA, fire, fired, flux, forMr, formula, Foundation, Francisco, gall, garden, GDPR, GPC, Greenergy, GSH, halt, halted, hand, harbor, HBV, hepatocyte, Hepsera, HITECH, hormone, importantly, inAdolescentNAFLD, inappropriate, indefinitely, intracellular, Inventiva, IP, Iran, Jaffa, Kazakhstan, knock, Kyrgyzstan, Lebanon, Maccabi, Madrigal, malfeasance, MCD, MEDecide, methionine, millioninvested, modelshare, MRP, multi, narrowly, NATI, Netta, Oakland, overpayment, oxygen, pattern, paymentin, pledge, Polypid, portal, preempted, reactive, Redhill, referenced, Reg, reproduce, Rescission, retrospectivemethod, Roundtable, Russian, scheme, scrutiny, searchable, sequence, sick, SK, spent, Steering, Stifel, TAA, telecommunication, Thiocatemide, thyroid, topline, transmission, transsulfuration, treble, UCSF, undefined, undelivered, underpaying, Viread, Vol, vulnerable, Wavelength, whistleblower, XBRL
Removed:
abusive, administratively, adult, allocation, antiretroviral, automobile, autumn, biomarker, Blacher, capture, career, Chapter, civilian, CMD, collaborating, covariance, culminating, Cyanamid, debarment, designing, dissuade, Dunnett, EndoPAT, escalate, escalation, estimation, explicitly, exploitation, exploratory, hired, Innapharma, inthe, Islamist, island, Itamar, Josh, leadership, Lebanese, Lederle, LIBOR, LIVERTest, MannKind, mediated, millionfor, missile, northern, overhaul, pace, presentedat, progressive, punitive, ratified, reexamination, remained, root, Rosetta, stratify, succeeded, sue, summer, violating, waste, Western, winter
Filing tables
Filing exhibits
GLMD similar filings
Filing view
External links
Exhibit 15.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement on Form S-8 (Registration No. 333-206292) and in the Registration Statement on Form F-3 (Registration No. 333-203133) of our report dated March 13, 2018 relating to the consolidated financial statements of Galmed Pharmaceuticals Ltd., (the “Company”), which appear in the Company's Annual Report on Form 20-F for the year ended December 31, 2017.
By: | /s/ Brightman Almagor Zohar & Co. | |
Certified Public Accountants | ||
Date: March 13, 2018 | A member firm of Deloitte Touche Tohmatsu Limited |